BR112015004231A2 - composição inalável, recipiente pressurizado cigarro simulado, método para a fabricação de uma composição, e, uso da composição - Google Patents

composição inalável, recipiente pressurizado cigarro simulado, método para a fabricação de uma composição, e, uso da composição

Info

Publication number
BR112015004231A2
BR112015004231A2 BR112015004231A BR112015004231A BR112015004231A2 BR 112015004231 A2 BR112015004231 A2 BR 112015004231A2 BR 112015004231 A BR112015004231 A BR 112015004231A BR 112015004231 A BR112015004231 A BR 112015004231A BR 112015004231 A2 BR112015004231 A2 BR 112015004231A2
Authority
BR
Brazil
Prior art keywords
composition
manufacture
pressurized container
inhalable
simulated cigarette
Prior art date
Application number
BR112015004231A
Other languages
English (en)
Other versions
BR112015004231B1 (pt
Inventor
Hearn Alex
Moyses Chris
Gupta Ritika
Bhimsen Lowe Stuart
Original Assignee
Kind Consumer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kind Consumer Ltd filed Critical Kind Consumer Ltd
Publication of BR112015004231A2 publication Critical patent/BR112015004231A2/pt
Publication of BR112015004231B1 publication Critical patent/BR112015004231B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/20—Devices without heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/60—Constructional details
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F47/00—Smokers' requisites not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F15/00—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor
    • A24F15/01—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor
    • A24F15/015—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor with means for refilling of liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/04—Tools for specific apparatus
    • A61M2209/045—Tools for specific apparatus for filling, e.g. for filling reservoirs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
BR112015004231-7A 2012-08-28 2013-08-23 composição inalável, recipiente pressurizado, cigarro simulado, e, método para a fabricação de uma composição BR112015004231B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1215273.2A GB201215273D0 (en) 2012-08-28 2012-08-28 Nicotine composition
GB1215273.2 2012-08-28
PCT/GB2013/052231 WO2014033437A2 (en) 2012-08-28 2013-08-23 Nicotine composition

Publications (2)

Publication Number Publication Date
BR112015004231A2 true BR112015004231A2 (pt) 2017-07-04
BR112015004231B1 BR112015004231B1 (pt) 2021-06-08

Family

ID=47045483

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015004231-7A BR112015004231B1 (pt) 2012-08-28 2013-08-23 composição inalável, recipiente pressurizado, cigarro simulado, e, método para a fabricação de uma composição

Country Status (25)

Country Link
US (1) US9655890B2 (pt)
EP (1) EP2890256B1 (pt)
JP (1) JP6185067B2 (pt)
KR (1) KR102256326B1 (pt)
CN (1) CN104768406B (pt)
AR (1) AR092261A1 (pt)
AU (1) AU2013308229B2 (pt)
BR (1) BR112015004231B1 (pt)
CA (1) CA2883379C (pt)
CL (1) CL2015000486A1 (pt)
DK (1) DK2890256T3 (pt)
ES (1) ES2902996T3 (pt)
GB (1) GB201215273D0 (pt)
HK (1) HK1211188A1 (pt)
IL (1) IL237467B (pt)
IN (1) IN2015DN02328A (pt)
MX (1) MX2015002476A (pt)
NZ (1) NZ706361A (pt)
PH (1) PH12015500686A1 (pt)
PL (1) PL2890256T3 (pt)
RU (1) RU2662550C2 (pt)
TW (1) TWI612979B (pt)
UA (1) UA115671C2 (pt)
WO (1) WO2014033437A2 (pt)
ZA (1) ZA201502013B (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10512282B2 (en) 2014-12-05 2019-12-24 Juul Labs, Inc. Calibrated dose control
GB2512325B (en) 2013-03-26 2016-06-22 Kind Consumer Ltd A pressurised refill canister with an outlet valve
GB2514758B (en) 2013-03-26 2015-06-24 Kind Consumer Ltd A Pressurised Refill Canister with an Outlet Valve
GB2512326B (en) 2013-03-26 2016-02-24 Kind Consumer Ltd A pressurised refill canister with an outlet valve
WO2015009862A2 (en) 2013-07-19 2015-01-22 Altria Client Services Inc. Liquid aerosol formulation of an electronic smoking article
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
PT3508080T (pt) 2013-12-23 2021-03-02 Juul Labs Int Inc Sistemas e métodos de dispositivo de vaporização
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
GB2524469A (en) 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
GB2524293B (en) 2014-03-19 2017-12-06 Kind Consumer Ltd An inhaler
KR20170003926A (ko) * 2014-04-08 2017-01-10 산사 코포레이션 (바베이도스) 인코포레이티드 니코틴 제형 및 이의 제조방법
JP6745728B2 (ja) * 2014-05-27 2020-08-26 アール・ジエイ・レイノルズ・タバコ・カンパニー ニコチン塩、共結晶、及び塩共結晶複合体
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB2528434A (en) * 2014-06-26 2016-01-27 Kind Consumer Ltd Nicotine dosage regimen
JP2017522293A (ja) * 2014-06-25 2017-08-10 カインド・コンシューマー・リミテッドＫｉｎｄ Ｃｏｎｓｕｍｅｒ Ｌｉｍｉｔｅｄ ニコチンの投与計画
GB2530980A (en) * 2014-09-19 2016-04-13 Kind Consumer Ltd Simulated cigarette
CN105054281B (zh) * 2015-07-21 2016-11-23 中国烟草总公司广东省公司 一种气雾型口香烟
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
GB2542389A (en) * 2015-09-17 2017-03-22 Kind Consumer Ltd Simulated cigarette
GB2542404B (en) * 2015-09-18 2019-08-14 Kind Consumer Ltd An inhalable composition and an inhaler
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
EP3379952B1 (en) * 2015-11-25 2023-12-06 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
CN105455190A (zh) * 2016-02-01 2016-04-06 湖北中烟工业有限责任公司 一种电子烟液
UA125687C2 (uk) 2016-02-11 2022-05-18 Джуул Лебз, Інк. Заповнювальний картридж випарного пристрою та способи його заповнення
MX2018009703A (es) 2016-02-11 2019-07-08 Juul Labs Inc Cartuchos de fijacion segura para dispositivos vaporizadores.
US20190046436A1 (en) * 2016-02-29 2019-02-14 Nicogen Ltd. Nicotine formulation and aerosols
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
WO2019198162A1 (ja) * 2018-04-10 2019-10-17 日本たばこ産業株式会社 霧化ユニット
JP7481269B2 (ja) 2018-06-28 2024-05-10 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 液体アルカロイド製剤を含むアルカロイド供与源を含むエアロゾル発生システムのためのカートリッジ
CN110754696A (zh) 2018-07-23 2020-02-07 尤尔实验室有限公司 用于蒸发器装置的气流管理
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201821088D0 (en) * 2018-12-21 2019-02-06 Nicoventures Trading Ltd Vaping monitor system and method
US11541004B2 (en) * 2020-06-10 2023-01-03 Howard University Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray
USD1028336S1 (en) 2021-06-22 2024-05-21 Pax Labs, Inc. Vaporizer cartridge
IT202100027086A1 (it) * 2021-10-21 2023-04-21 Alberto Patarchi Erogatore portatile per il trattamento o la prevenzione di un’infezione o di una patologia causata da un virus
WO2023154983A1 (en) * 2022-02-18 2023-08-24 Inhaler Supplies Pty Ltd Nicotine formulation
WO2023157208A1 (ja) * 2022-02-18 2023-08-24 日本たばこ産業株式会社 たばこ製品、非燃焼性加熱型香味吸引器具、たばこ製品の製造方法
CN115813006B (zh) * 2022-09-05 2023-08-18 东莞市鸿馥生物科技有限公司 一种能够提高果香的电子烟液及其制备方法
KR20240049697A (ko) 2022-10-07 2024-04-17 주식회사 케이티앤지 에어로졸 흡입기용 액상 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1017032A (en) * 1963-12-12 1966-01-12 Aerosmoke Ltd Aerosol compositions
JPS63148973A (ja) * 1987-07-08 1988-06-21 大日精化工業株式会社 かぎ煙草
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
CN101084801A (zh) * 2003-04-29 2007-12-12 韩力 一种非可燃性电子喷雾香烟
US20060018840A1 (en) * 2004-06-28 2006-01-26 Nektar Therapeutics Aerosolizable formulation comprising nicotine
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
WO2009111037A2 (en) * 2008-03-04 2009-09-11 Indigene Pharmaceuticals Inc. Compositions and methods for treating nos-associated diseases
GB0808154D0 (en) * 2008-05-06 2008-06-11 British American Tobacco Co Aerosol dispensing device
GB0823491D0 (en) * 2008-12-23 2009-01-28 Kind Consumer Ltd A simulated cigarette device
CN102080276B (zh) * 2009-11-30 2014-05-14 合肥中科绿色家电科技有限公司 可生物降解的烟用纤维材料及香烟过滤嘴
GB201003552D0 (en) * 2010-03-03 2010-04-21 Kind Consumer Ltd A simulated cigarette
EP2460422A1 (en) * 2010-12-03 2012-06-06 Philip Morris Products S.A. An aerosol generating system with provention of condensate leakage
EP2468117A1 (en) * 2010-12-24 2012-06-27 Philip Morris Products S.A. An aerosol generating system having means for determining depletion of a liquid substrate
CN102266125B (zh) 2011-07-28 2013-01-09 易侧位 一种中药戒烟电子烟
US8646461B2 (en) * 2011-12-14 2014-02-11 Sentiens, Llc Device and method for simulating chemosensation of smoking

Also Published As

Publication number Publication date
CA2883379A1 (en) 2014-03-06
EP2890256B1 (en) 2021-10-27
ES2902996T3 (es) 2022-03-30
US9655890B2 (en) 2017-05-23
CN104768406A (zh) 2015-07-08
AU2013308229B2 (en) 2019-05-09
PH12015500686B1 (en) 2015-06-08
IL237467B (en) 2018-12-31
TWI612979B (zh) 2018-02-01
IL237467A0 (en) 2015-04-30
IN2015DN02328A (pt) 2015-08-28
TW201410274A (zh) 2014-03-16
CN104768406B (zh) 2018-11-16
US20150297580A1 (en) 2015-10-22
BR112015004231B1 (pt) 2021-06-08
PH12015500686A1 (en) 2015-06-08
MX2015002476A (es) 2015-06-05
JP2015527071A (ja) 2015-09-17
KR20150046318A (ko) 2015-04-29
DK2890256T3 (da) 2022-01-17
HK1211188A1 (en) 2016-05-20
EP2890256A2 (en) 2015-07-08
AR092261A1 (es) 2015-04-08
WO2014033437A3 (en) 2014-06-26
PL2890256T3 (pl) 2022-02-21
JP6185067B2 (ja) 2017-08-23
UA115671C2 (uk) 2017-12-11
CL2015000486A1 (es) 2015-10-02
GB201215273D0 (en) 2012-10-10
ZA201502013B (en) 2016-10-26
RU2662550C2 (ru) 2018-07-26
WO2014033437A2 (en) 2014-03-06
RU2015110686A (ru) 2016-10-20
AU2013308229A1 (en) 2015-04-09
CA2883379C (en) 2016-11-15
KR102256326B1 (ko) 2021-05-26
NZ706361A (en) 2018-05-25

Similar Documents

Publication Publication Date Title
BR112015004231A2 (pt) composição inalável, recipiente pressurizado cigarro simulado, método para a fabricação de uma composição, e, uso da composição
IL269054A (en) A pharmaceutical preparation containing tesimaltone for use in the treatment of 24-NON
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
CL2014003386A1 (es) Métodos y composiciones para producción de biometano
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
BR112014028755A2 (pt) composição de argamassa de poliuretano, processo para preparação da composição de argamassa de poliuretano, e, uso de uma composição de argamassa de poliuretano.
BR112015002091A2 (pt) método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
BR112014028647A2 (pt) composições e métodos para modulação da expressão de bdnf
BR112013021274A2 (pt) composição cosmética botânica bioativa, formulação cosmética botânica bioativa, e método para preparar uma composição cosmética botânica bioativa
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
BR112014030044A2 (pt) uma composição na forma de uma dispersão compreendendo uma lignina , um método para a manufaturação da mesma e utilização da mesma
BR112014015042A2 (pt) composição farmacêutica, e, método para obter uma composição radiofarmacêutica
BR112014028725A2 (pt) artigo adesivo, construções adesivas e métodos para preparar uma construção adesiva
BR112015011262A2 (pt) artigo absorvente e método para produzir um artigo absorvente
BR112015022347A2 (pt) composição para vacinação, método para produzir uma composição para vacinação e uso de composição
BR112013015085A2 (pt) composição farmacêutica, método para preparar uma composição, e, uso de composição
BR112013013581A2 (pt) composição de graxa, componente mecânico, uso da composição de graxa, e, método para preparação de uma composição de graxa
BR112014017445A2 (pt) composição, uso de uma composição, corpo lignocelulósico, e, método para preparar uma composição
BR112014026564A2 (pt) formulação, uso de uma formulação, e, processo para a preparação de uma formulação
BR112014026565A2 (pt) formulação, uso de uma formulação, e, processo para produzir uma formulação
BR112014014285A2 (pt) composição, e, método para fabricar uma composição
BR112014031513A2 (pt) composição alimentícia concentrada, processo para preparar uma composição alimentícia concentrada e uso da composição
EP3037099A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
EP2786982A4 (en) AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/08/2013, OBSERVADAS AS CONDICOES LEGAIS.